Recent Publications by Members of the Bone and Musculoskeletal Study Group

The use of crevicular fluid to assess markers of inflammation and angiogenesis, IL-17 and VEGF, in patients with solid tumors receiving zoledronic acid and/or bevacizumab. Papadopoulou E, Nicolatou-Galitis O, Papassotiriou I, Linardou H, Karagianni A, Tsixlakis K, et al. Support Care Cancer. 2019 Apr 17. [Epub ahead of print]

Bone-targeted agent treatment patterns and the impact of bonemetastases on patients with advanced breast cancer in the United States. Henry D, von Moos R, Body JJ, Rider A, De Courcy J, Bhowmik D et al. Curr Med Res Opin. 2019 Mar;35(3):375-381.

Medication-related osteonecrosis of the jaw: definition and best practice for prevention, diagnosis, and treatment. Nicolatou-Galitis O, Schiødt M, Mendes RA, Ripamonti C, Hope S, Drudge-Coates L et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2019 Feb;127(2):117-135. Review. Free Article

Osteonecrosis of the jaw related to non-antiresorptive medications: a systematic review. Nicolatou-Galitis O, Kouri M, Papadopoulou E, Vardas E, Galiti D, Epstein JB, Elad S et al; MASCC Bone and Musculoskeletal Study Group. Support Care Cancer. 2019 Feb;27(2):383-394.

International validation of the revised European Organisation for Research and Treatment of Cancer Head and Neck Cancer Module, the EORTC QLQ-HN43: Phase IV. Singer S, Amdal CD, Hammerlid E, Tomaszewska IM, Castro Silva J, Mehanna H, et al; EORTC Quality of Life and the EORTC Head and Neck Cancer Groups. Head Neck. 2019 Jan 12. [Epub ahead of print]

Bone management in hematologic stem cell transplant recipients. Kendler DL, Body JJ, Brandi ML, Broady R, Cannata-Andia J, Cannata-Ortiz MJ et al; International Osteoporosis Foundation Committee of Scientific Advisors Working Group on Cancer and Bone Disease. Osteoporos Int. 2018 Dec;29(12):2597-2610.

A real-world study assessing the use of bone-targeted agents and their impact on bone metastases in patients with prostate cancertreated in clinical practice in Europe. Body JJ, von Moos R, Rider A, Hallworth P, Bhowmik D, Gatta F et al. J Bone Oncol. 2018 Dec 18;14:100212. eCollection 2019 Feb. Free PMC Article

The effects of high-dose calcitriol and individualized exercise on bone metabolism in breast cancer survivors on hormonal therapy: a phase II feasibility trial. Peppone LJ, Ling M, Huston AJ, Reid ME, Janelsins MC, Puzas JE et al. Support Care Cancer. 2018 Aug;26(8):2675-2683.

Physicians' preferences for bone metastases treatments in France, Germany and the United Kingdom. Qian Y, Arellano J, Gatta F, Hechmati G, Hauber AB, Mohamed AF et al. BMC Health Serv Res. 2018 Jul 3;18(1):518.  Free PMC Article

A multicenter case registry study on medication-related osteonecrosis of the jaw in patients with advanced cancer. Schødt M, Vadhan-Raj S, Chambers MS, Nicolatou-Galitis O, Politis C, Coropciuc R et al. Support Care Cancer. 2018 Jun;26(6):1905-1915.

Fractures frequently occur in older cancer patients: the MD Anderson Cancer Center experience. Edwards BJ, Sun M, Zhang X, Holmes HM, Song J, Khalil P et al. Support Care Cancer. 2018 May;26(5):1561-1568.

Healthcare-resource utilization associated with radiation to boneacross eight European countries: Results from a retrospective study. von Moos R, Body JJ, Guenther O, Terpos E, Acklin YP, Finek J. J Bone Oncol. 2018 Feb 5;10:49-56.

Osteonecrosis of the jaw (ONJ) in patients who receive BoneTargeting Agents (BTAs): the power of e-learning. Nicolatou-Galitis O, Migliorati C. Ecancermedicalscience. 2018 Jan 23;12:ed77. eCollection 2018. Free PMC Article

Bone-targeted agent treatment patterns and the impact of bonemetastases on patients with advanced breast cancer in real-world practice in six European countries. von Moos R, Body JJ, Rider A, de Courcy J, Bhowmik D, Gatta F et al. J Bone Oncol. 2017 Nov 24;11:1-9. Free PMC Article

Developing drugs in cancer-related bone pain. Lucchesi M, Lanzetta G, Antonuzzo A, Rozzi A, Sardi I, Favre C, Ripamonti CI et al. Crit Rev Oncol Hematol. 2017 Nov;119:66-74. 

Skeletal health in breast cancer survivors. Bruyère O, Bergmann P, Cavalier E, Gielen E, Goemaere S, Kaufman JM et al. 2017 Nov;105:78-82.

Osteoporosis Risk Calculators. Edwards BJ. J Clin Densitom. 2017 Jul - Sep;20(3):379-388. Review.

An observational time and motion study of denosumab subcutaneous injection and zoledronic acid intravenous infusion in patients with metastatic bone disease: results from three European countries. Body JJ, Gatta F, De Cock E, Tao S, Kritikou P, Wimberger P, Mebis J, Peeters M, Pedrazzoli P, Caraceni A, Adamo V, Hechmati G. Support Care Cancer. 2017 Sep;25(9):2823-2832. Free PMC Article

Osteoporosis in Frail Patients: A Consensus Paper of the Belgian Bone Club. Gielen E, Bergmann P, Bruyère O, Cavalier E, Delanaye P, Goemaere S et al. Calcif Tissue Int. 2017 Aug;101(2):111-131.Review. Free PMC Article

Systematic review and meta-analysis on the proportion of patients with breast cancer who develop bone metastases. Body JJ, Quinn G, Talbot S, Booth E, Demonty G, Taylor A et al. Crit Rev Oncol Hematol. 2017 Jul;115:67-80. Review. Free Article

Hypercalcaemia and hypocalcaemia: finding the balance. Body JJ, Niepel D, Tonini G. Support Care Cancer. 2017 May;25(5):1639-1649. Review. Free PMC Article

Clinical registry of dental outcomes in head and neck cancer patients (OraRad): rationale, methods, and recruitment considerations. Lalla RV, Long-Simpson L, Hodges JS, Treister N, Sollecito T, Schmidt B, Patton LL, Brennan MT; OraRad Study Group. BMC Oral Health. 2017 Feb 27;17(1):59.  Free PMC Article

Hypercalcaemia and hypocalcaemia: finding the balance. Body JJ, Niepel D, Tonini G. Support Care Cancer. 2017 May;25(5):1639-1649. Free PMC Article

Improving quality of life in patients with advanced cancer: Targeting metastatic bone pain.  von Moos R, Costa L, Ripamonti CI, Niepel D, Santini D. Eur J Cancer. 2017 Jan;71:80-94.  Free Article

Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. Khan AA, Morrison A, Kendler DL, Rizzoli R, Hanley DA, Felsenberg D, McCauley LK, et al; International Task Force on Osteonecrosis of the Jaw. J Clin Densitom. 2017 Jan - Mar;20(1):8-24.

Ibandronate for the prevention of bone loss after allogeneic stem cell transplantation for hematologic malignancies: a randomized-controlled trial. Lu H, Champlin RE, Popat U, Pundole X, Escalante CP, Wang X, Qiao W, Murphy WA, Gagel RF. Bonekey Rep. 2016 Oct 19;5:843. 

Managing Osteoporosis in Patients on Long-Term Bisphosphonate Treatment: Report of a Task Force of the American Society for Bone and Mineral Research.  Adler RA, El-Hajj Fuleihan G, Bauer DC, Camacho PM, Clarke BL, Clines GA, Compston JE, Drake MT, Edwards BJ et al. J Bone Miner Res. 2016 Oct;31(10):1910.

Prevention and management of osteonecrosis of the jaw secondary to bone-targeted therapy in patients with kidney cancer. Ripamonti CI, Lucchesi M, Giusti R.Curr Opin Support Palliat Care. 2016 Sep;10(3):273-80.

Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center Experience. Edwards BJ, Sun M, West DP, Guindani M, Lin YH, Lu H, et al. J Bone Miner Res. 2016 Aug;31(8):1569-76.

Health resource utilization associated with skeletal-related events: results from a retrospective European study. Body JJ, Pereira J, Sleeboom H, Maniadakis N, Terpos E, Acklin YP et al. Eur J Health Econ. 2016 Jul;17(6):711-21.  Free PMC Article

Cost of skeletal complications from bone metastases in six European countries.  Pereira J, Body JJ, Gunther O, Sleeboom H, Hechmati G, Maniadakis N, et al. J Med Econ. 2016 Jun;19(6):611-8.

Bone health and breast cancer: Management overview of bone health in breast cancer. Tan WW, Harris JE, Shepard RC, Stopeck AT, Swart R, Downey L, et al. Medscape. May, 2016.

Resection of granulomatous tissue resolves silicone induced hypercalcemia, Edwards BJ, Saraykar S, Sun M,  Murphy WA Jr., Lin P, Gagel R. Bone Reports 5 (2016):163-7.

Pain and analgesic use associated with skeletal-related events in patients with advanced cancer and bone metastases. von Moos R, Body JJ, Egerdie B, Stopeck A, Brown J, Fallowfield L et al. Support Care Cancer. 2016 Mar;24(3):1327-37.  Free PMC Article

Adjuvant bisphosphonates in early breast cancer: consensus guidance for clinical practice from a European Panel. Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ et al. Ann Oncol. 2016 Mar;27(3):379-90.

Elevated incidence of fractures in women with invasive breast cancer. Edwards BJ, Gradishar WJ, Smith ME, Pacheco JA, Holbrook J, McKoy JM et al. Osteoporos Int. 2016 Feb;27(2):499-507.

Osteonecrosis of the jaw in a patient with acute myeloid leukemia, who received azacitidine. Nicolatou-Galitis O, Galiti D, Moschogianni M, Sachanas S, Edwards BJ, Migliorati CA, Pangalis G.  J Cancer Metasta Treat 2016;2:220-3.

Safety of long-term denosumab therapy: results from the open label extension phase of two phase 3 studies in patients with metastatic breast and prostate cancer. Stopeck AT, Fizazi K, Body JJ, Brown JE, Carducci M, Diel I et al. Support Care Cancer. 2016 Jan;24(1):447-55.  Free PMC Article

Periodontal disease preceding osteonecrosis of the jaw (ONJ) in cancer patients receiving antiresorptives alone or combined with targeted therapies: report of 5 cases and literature review. Nicolatou-Galitis O, Razis E, Galiti D, Galitis E, Labropoulos S, Tsimpidakis A et al. Oral Surg Oral Med Oral Pathol Oral Radiol. 2015 Dec;120(6):699-706.

Anticancer effects of vitamin D. Edwards BJ.  American Journal of Hematology/Oncology, 2015 (11): 26-36.

ESMO Guidelines Working Group. Bone Health in Cancer Patients: ESMO Clinical Practice Guidelines. Coleman R, Body JJ, Aapro M, Hadji P, Herrstedt J; Ann Oncol. 2014 Sep;25 Suppl 3:iii124-37. Free Full Text

5-year follow-up of a randomized controlled trial of immediate versus delayed zoledronic acid for the prevention of bone loss in postmenopausal women with breast cancer starting letrozole after tamoxifen: N03CC (Alliance) trial. Wagner-Johnston ND, Sloan JA, Liu H, Kearns AE, Hines SL, Puttabasavaiah S, Dakhil SR, Lafky JM, Perez EA, Loprinzi CL. Cancer. 2015 Aug 1;121(15):2537-43.

Endpoint comparison for bone mineral density measurements in North Central Cancer Treatment Group cancer clinical trials N02C1 and N03CC (Alliance). Dueck AC, Singh J, Atherton P, Liu H, Novotny P, Hines S, Loprinzi CL, et al; Alliance for Clinical Trials in Oncology. Osteoporos Int. 2015 Jul;26(7):1971-7.

Dental extractions as the major local risk factor of bisphosphonates related jaw osteonecrosis in cancer patients receiving intravenous bisphosphonates therapy. A systematic review. Vardas, E., Coward, T., Papadopoulou, E., Nicolatou-Galitis, O. Mediterranean Oncol J MOJ. 2014;1:26–33.

Stomatitis, gingivitis and periodontal abscess in a patient with metastatic renal cell carcinoma receiving temsirolimus and bevacizumab: A cumulative toxicity? Nicolatou-Galitis O, Koutsoukos KA, Galitis E, Bamias A, Dimopoulos MA.  Mediterranean Oncol J MOJ 2014;1:45-49.

Osteonecrosis of the jaw in a patient with chronic myelogenous leukemia receiving imatinib - A case report with clinical implications. Nicolatou-Galitis, O, Razis E., Galiti D, Vardas E, Tzerbos F, Labropoulos S. Forum of Clinical Oncology, December 2013.